Concepedia

Author

P Hernández

Instituto de Hematología e InmunologíaORCID

Also Known As

Andrés Torres, Asensio Hernández, Pablo, P Hernandez, P Hernańdez, P Hernández, P. Hernandez, P. Hernández, P. Simal Hernández, Paola Elizabeth Galván Hernández, Paola Silerio Hernández

52

Publications

437

Citations

10

H-Index

29

Concepts

All Affiliations

Instituto de Hematología e Inmunología
PH

About

P Hernández is an author at Instituto de Hematología e Inmunología specializing in medicine, hematology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

190

2

Health Sciences

2

2

32

3

Cellular Therapies

1

1

63

4

Emergency Medicine

1

1

79

5

Hepatology

1

1

21

P Hernández

×

7

Publications

307

Citations

7

H-Index

YearCitations

Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy

Gustavo Deza, Marta Bertolín‐Colilla, Ramón M. Pujol,

Acta Dermato Venereologica

2017

107

Cardiovascular autonomic dysfunction in sickle cell anemia: A possible risk factor for sudden death?

Juan C Romero Mestre, Alicia Hernández Hernández, Olga Agramonte,

Clinical Autonomic Research

1997

79

Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: A comparison of using blood cell separator and Ficoll density gradient centrifugation

P Hernández, Lázaro Cortina, H. Artaza,

Atherosclerosis

2006

63

Clinical features of hepatic sequestration in sickle cell anaemia.

P Hernández, E. Dorticós, Etual Espinosa,

PubMed

1989

21

Parotid and central nervous system relapse during complete hematologic remission in acute promyelocytic leukemia.

Mesa, E. Espinosa, Rafael Losada,

PubMed

1999

16

Successful treatment of acute promyelocytic leukemia using all- trans retinoic acid and erythropoietin in a Jehovah's Witness boy

Adrián Cid Menéndez, Eva Svarch, P Hernández

Annals of Hematology

1998

11

A phase II nonrandomized study of nab-paclitaxel plus carboplatin in patients with recurrent platinum-sensitive ovarian or primary peritoneal cancer.

Benedict B. Benigno, M. O. Burrell, Penny Daugherty,

Journal of Clinical Oncology

2010

10

Page 1